CN207605066U - A kind of medical dressing being freely disassembled combination - Google Patents
A kind of medical dressing being freely disassembled combination Download PDFInfo
- Publication number
- CN207605066U CN207605066U CN201720034557.6U CN201720034557U CN207605066U CN 207605066 U CN207605066 U CN 207605066U CN 201720034557 U CN201720034557 U CN 201720034557U CN 207605066 U CN207605066 U CN 207605066U
- Authority
- CN
- China
- Prior art keywords
- dressing
- silicone gel
- freely disassembled
- medical
- wound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 37
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 16
- 229920000615 alginic acid Polymers 0.000 claims abstract description 12
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 12
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims abstract description 6
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims abstract description 6
- 229940126864 fibroblast growth factor Drugs 0.000 claims abstract description 6
- 229920001661 Chitosan Polymers 0.000 claims abstract description 4
- 230000000694 effects Effects 0.000 claims description 12
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 229920002529 medical grade silicone Polymers 0.000 claims description 5
- -1 polyethylene Polymers 0.000 claims description 5
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 239000002759 woven fabric Substances 0.000 claims 2
- 230000035876 healing Effects 0.000 abstract description 11
- 230000006870 function Effects 0.000 abstract description 10
- 231100000241 scar Toxicity 0.000 abstract description 5
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 4
- 230000023597 hemostasis Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- 230000004520 agglutination Effects 0.000 abstract description 3
- 230000000202 analgesic effect Effects 0.000 abstract description 3
- 238000005213 imbibition Methods 0.000 abstract description 3
- 239000000499 gel Substances 0.000 description 31
- 208000027418 Wounds and injury Diseases 0.000 description 26
- 206010052428 Wound Diseases 0.000 description 25
- 239000010408 film Substances 0.000 description 13
- 230000029663 wound healing Effects 0.000 description 7
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical group CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 5
- 238000004806 packaging method and process Methods 0.000 description 5
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical compound O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000010181 polygamy Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000015590 smooth muscle cell migration Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The utility model patent belongs to medical dressing field, it can be freely disassembled combination medical dressing more particularly to one kind, include dressing A and dressing B, for the dressing A from top to bottom successively by back sheet, the first silicone gel, froth bed, the second silicone gel, hydrophobic film layer and alginates nonwoven layer, the dressing B is the chitosan nonwoven layer that load has water-solubleazone and fibroblast growth factor.Dressing prepared by the utility model has imbibition, hemostasis, analgesic, antibacterial, promoting healing, inhibits the multiple functions such as scar, it can be according to the surface of a wound feature and demand different in agglutination, it is freely disassembled and is combined, different functions is provided, accelerate the healing of the surface of a wound.
Description
Technical field
The utility model belongs to medical dressing field, and in particular to a kind of medical dressing being freely disassembled combination.
Background technology
The surface of a wound passes through the different stages in the process of healing, intersects between each stage, is overlapped, and being related to a variety of
The common participation of the ingredients such as inflammatory cell, repair cell, growth factor.There is a large amount of wound fluid at the initial stage of wound healing
And diffusate, and with pain, inflammation etc., exist simultaneously the risk of easy infection.In the later stage of wound healing, it is easy to form scar
Trace influences the effect of wound healing.
Environment residing for wound healing and wound is closely bound up.As the feeling of pain of wound can influence the reconstruction of blood vessel, and
And the oxygen supply of skin histology is reduced, to influence the healing rate of the surface of a wound.Mechanical tension suffered by the surface of a wound can oppress
Remaining capilary on wound, influences nutritional ingredient and oxygen enters wound, causes the further destruction of the surface of a wound, influences the surface of a wound
Healing effect.Contain a large amount of inflammatory mediator and inflammatory cell in wound fluid, such as clear up not in time, be easy to cause bacterium taste
It is raw, lead to wound infection.
There are mainly two types of existence forms for existing dressing：It is relatively simple that one is functions, cannot meet the surface of a wound, especially multiple
The demand of polygamy wound healing；Another kind is that function is relatively more, and integration cannot be closed according to the different phase of wound healing
The selection of reason.
Water-solubleazone is a kind of chemical substance, and molecular formula is C18H35NO,
Chinese is azone, Azone, Azone, the N- months
Osmanthus base caprolactam, Azone,
English name is Azone.
Fibroblast growth factor（fibroblast growth factor,FGF）There are several isomers, it is hard in artery
Change the mainly bFGF to work in stove（basic fibroblast growth factor）, bFGF can by endothelial cell,
Smooth muscle cell, macrophages secrete.Its effect is the proliferation of the migration and smooth muscle cell that promote endothelial cell, cannot be made
Smooth muscle cell migration.It can promote neovascularization, repair the endothelial cell of damage.FGF is considered as that lesion forms promotion
The factor, but it also has advantageous one side in terms of reparation angle.Letter is fibroblast growth factor to claim FGF, foreign language.
Invention content
Utility model aims to solve deficiency in the prior art, provides and a kind of being freely disassembled the medical of combination
Dressing.Dressing prepared by the utility model has imbibition, hemostasis, analgesic, antibacterial, promoting healing, inhibits the multiple functions such as scar, can
It according to the surface of a wound feature and demand different in agglutination, is freely disassembled and is combined, different functions is provided, accelerate wound
The healing in face.
To achieve the above object, the technical solution of the utility model is as follows：A kind of medical dressing being freely disassembled combination,
Include dressing A and dressing B, the dressing A is from top to bottom successively by back sheet, the first silicone gel, froth bed, the second silicon
Ketone gel layer, hydrophobic film layer and alginates nonwoven layer are constituted, and the dressing B, which is load, has water-solubleazone and at fiber finer
The chitosan nonwoven layer of the intracellular growth factor.
Preferably, first silicone gel is that medical silicone gel coating is formed in the lower surface of back sheet.
Preferably, the upper surface of the froth bed under the viscous effect of the first silicone gel with the first silicone gel
Mutually adhere to.
Preferably, second silicone gel is that medical silicone gel coating is formed in the lower surface of froth bed.
Preferably, the upper surface of the hydrophobic film layer is solidifying with the second silicone under the viscous effect of the second silicone gel
Glue-line mutually adheres to.
Preferably, the alginates nonwoven layer is carried out with hydrophobic film layer by way of heat seal compound.
Preferably, the hydrophobic film layer is polyethylene film.
Preferably, the dressing A can be by removing hydrophobic film layer and alginates nonwoven layer, then by the dressing B
It is mutually adhered to the second silicone gel under the viscous effect of the second silicone gel, forms the dressing with different function.
Preferably, the dressing A and dressing B is sterile product, can be to be placed in again in same packaging bag after independent packaging.
The beneficial effects of the utility model are：
（1）Dressing prepared by the utility model has imbibition, hemostasis, analgesic, antibacterial, promoting healing, inhibition scar etc. a variety of
Function can be freely disassembled and combined, provide different work(according to the surface of a wound feature and demand different in agglutination
Can, accelerate the healing of the surface of a wound.
（2）Dressing prepared by the utility model has good biocompatibility, will not cause allergic reaction.
（3）Dressing prepared by the utility model, it is simple for process, it is vdiverse in function, the need of patient and medical worker can be met
It asks, good solution is provided for the treatment and nursing of the surface of a wound.
Description of the drawings
Fig. 1 is a kind of structure being freely disassembled dressing A in combination medical dressing of the utility model；
Reference sign：1- back sheets；The first silicone gels of 2-；3- froth beds；The second silicone gels of 4-；5- is dredged
Water thin film layer；6- alginates nonwoven layers.
Specific implementation mode
The technical solution of the utility model is described further with reference to embodiment.
A kind of medical dressing being freely disassembled combination includes dressing A with dressing B, the dressing A from top to bottom successively
By back sheet 1, the first silicone gel 2, froth bed 3, the second silicone gel 4, hydrophobic film layer 5 and alginates nonwoven layer
6 are constituted, and the dressing B is the chitosan nonwoven layer that load has water-solubleazone and fibroblast growth factor；Described
One silicone gel 2 is that medical silicone gel coating is formed in the lower surface of back sheet 1；The upper surface of the froth bed 3 is
It is adhered to 2 phase of the first silicone gel under the viscous effect of one silicone gel 2；Second silicone gel 4 is medical silicon
Ketone gel coating is formed in the lower surface of froth bed；Viscosity of the upper surface of the hydrophobic film layer 5 in the second silicone gel 4
Effect is lower to be adhered to 4 phase of the second silicone gel；The alginates nonwoven layer 6 is with hydrophobic film layer 5 by way of heat seal
It carries out compound；The hydrophobic film layer 5 is polyethylene film；The dressing A can be by removing hydrophobic film layer 5 and alginates
Nonwoven layer 6, then the dressing B is adhered under the viscous effect of the second silicone gel 4 with 4 phase of the second silicone gel,
Form the dressing with different function；The dressing A and dressing B is sterile product, can be same to be placed in again after independent packaging
In packaging bag.
During use：（1）The outer packing of dressing is opened, dressing A is taken out, before use, cleaning treatment first is carried out to wound,
The alginates nonwoven layer 6 of dressing A is directed at the surface of a wound, absorbs a large amount of diffusate of the surface of a wound by the packaging for opening dressing A, utilizes the
One silicone gel 2 is fixed on surface of a wound surrounding normal skin.（2）After dressing A uses 2 ~ 8 h（The specifically used time can basis
Surface of a wound degree of injury and wound fluid determine）, dressing is opened, alginates nonwoven layer 6 of dismantling and hydrophobic film layer 5 expose
Second silicone gel 4 is combined dressing B on dressing A using the stickiness of the second silicone gel 4.This operation can be the surface of a wound
Clean healing environment is provided, while dressing B has effects that antibacterial, hemostasis, inhibition of pain and promoting healing, replaces with dressing B
Be conducive to the healing of the surface of a wound.（3）After surface of a wound surface forms one layer of new epidermis, froth bed 3, the second silicone gel can be removed
Layer 4 is equal and 1 and first silicone gel 2 of remaining back sheet, the first silicone gel 2 are contacted with the surface of a wound, can inhibit scar
Growth.
It should be noted that it is clear that attached drawing of this specification or more is only to the description of the drawings and the specific embodiments
Ground illustrates the utility model example, is not the restriction to the embodiment of the utility model.It is all in the utility model
Spirit and principle within made by all any modification, equivalent and improvement etc., should be included in the utility model claims
Protection domain within.
Claims (7)
1. a kind of medical dressing being freely disassembled combination, which is characterized in that include dressing A with dressing B, the dressing A from
Top to bottm successively by back sheet, the first silicone gel, froth bed, the second silicone gel, hydrophobic film layer and alginates without
Woven fabric layer is constituted, and the dressing B is the chitosan nonwoven layer that load has water-solubleazone and fibroblast growth factor.
2. a kind of medical dressing being freely disassembled combination according to claim 1, which is characterized in that first silicone
Gel layer is that medical silicone gel coating is formed in the lower surface of back sheet.
3. a kind of medical dressing being freely disassembled combination according to claim 1, which is characterized in that the froth bed
Upper surface mutually adheres under the viscous effect of the first silicone gel with the first silicone gel.
4. a kind of medical dressing being freely disassembled combination according to claim 1, which is characterized in that second silicone
Gel layer is that medical silicone gel coating is formed in the lower surface of froth bed.
5. a kind of medical dressing being freely disassembled combination according to claim 1, which is characterized in that the hydrophobic film
The upper surface of layer mutually adheres under the viscous effect of the second silicone gel with the second silicone gel.
6. a kind of medical dressing being freely disassembled combination according to claim 1, which is characterized in that the alginates without
Woven fabric layer is carried out with hydrophobic film layer by way of heat seal compound.
7. a kind of medical dressing being freely disassembled combination according to claim 1, which is characterized in that the hydrophobic film
Layer is polyethylene film.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201720034557.6U CN207605066U (en) | 2017-01-12 | 2017-01-12 | A kind of medical dressing being freely disassembled combination |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201720034557.6U CN207605066U (en) | 2017-01-12 | 2017-01-12 | A kind of medical dressing being freely disassembled combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN207605066U true CN207605066U (en) | 2018-07-13 |
Family
ID=62791925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201720034557.6U Expired - Fee Related CN207605066U (en) | 2017-01-12 | 2017-01-12 | A kind of medical dressing being freely disassembled combination |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN207605066U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108635106A (en) * | 2018-07-17 | 2018-10-12 | 胡俊 | Subtract tensioning and closes dressing |
| CN114225093A (en) * | 2021-12-22 | 2022-03-25 | 振德医疗用品股份有限公司 | Antibacterial dressing with composite function and preparation method thereof |
-
2017
- 2017-01-12 CN CN201720034557.6U patent/CN207605066U/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108635106A (en) * | 2018-07-17 | 2018-10-12 | 胡俊 | Subtract tensioning and closes dressing |
| CN114225093A (en) * | 2021-12-22 | 2022-03-25 | 振德医疗用品股份有限公司 | Antibacterial dressing with composite function and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2694907C2 (en) | Adhesive film dressing for medical compression | |
| CN106822988A (en) | Alginate fibre functional dressing and its application, alginate fibre functional dressing patch | |
| CN108686255A (en) | It is a kind of to prevent the biological dressing and preparation method thereof that scar is formed | |
| CN207605066U (en) | A kind of medical dressing being freely disassembled combination | |
| Brown et al. | Quick reference to wound care | |
| CN205126571U (en) | Belly area base of a fruit flap supplies lamella to distinguish device of applying ointment or plaster | |
| Brongo et al. | Reconstruction of traumatic defect of the lower third of the leg using a combined therapy: negative pressure wound therapy, acellular dermal matrix, and skin graft | |
| Rajendran et al. | High performance textiles for wound care | |
| CN104720979B (en) | A kind of rescue of battlefield Multifunctional sterile dressing patch and its application method | |
| Wipke-Tevis et al. | Management of vascular leg ulcers | |
| CN204208067U (en) | Plaster | |
| CN204379552U (en) | The preoperative aseptic elastic bandage of a kind of hip replacement | |
| CN209450779U (en) | A kind of moisturizing dressing inhibiting scar | |
| CN203802669U (en) | Wet tissue for medical use | |
| CN204814414U (en) | Utilize woundplast of nanometer silver sterilization | |
| CN204446301U (en) | A kind of medical cream isolation is pasted | |
| CN219614204U (en) | Chitosan slow-release microsphere-based band-aid | |
| CN202336082U (en) | Chitosan disinfectant dressing patch | |
| CN204106310U (en) | A kind of novel icing cover | |
| CN103892962A (en) | Nanometer type sterilization and bleeding stopping operation towel | |
| CN2657600Y (en) | Bridge frame for wound | |
| CN203280585U (en) | Pressing band used for fixing limb wound dressing | |
| CN102228717A (en) | Medical multifunctional oily yarn and preparation method thereof | |
| CN208591334U (en) | Honey sterilizes bandage | |
| Gerall et al. | Split Thickness Skin Graft (STSG) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180713 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |